Screener
Fennec Pharmaceuticals FENC Q1 2026 earnings
Reported May 14, 2026 · Before market open
Revenue$15.1MBeat by $1.2M
EPS$0.01Beat by $0.03
Revenue estimate$13.9M
EPS estimate-$0.02
Next report
Date not yet announcedVersus estimates
Revenue
Diluted EPS
FAQ
- When did Fennec Pharmaceuticals report Q1 2026 earnings?
- Fennec Pharmaceuticals (FENC) reported Q1 2026 earnings on May 14, 2026 before market open.
- What were Fennec Pharmaceuticals's Q1 2026 revenue and EPS?
- Fennec Pharmaceuticals reported revenue of $15.1M and eps of $0.01 for Q1 2026.
- Did Fennec Pharmaceuticals beat estimates in Q1 2026?
- Revenue beat the consensus estimate of $13.9M by $1.2M. EPS beat the consensus estimate of $-0.02 by $0.03.
- How did Fennec Pharmaceuticals's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 72.6% from $8.8M a year earlier.
- Where can I find Fennec Pharmaceuticals's Q1 2026 SEC filings?
- You can read the 10-Q periodic report (0001104659-26-061213) directly on SEC EDGAR. The filing index links above go to sec.gov.
